Review
doi: 10.2165/00003495-199346050-00006.
Drug treatment for hyperactive children. Therapeutic guidelines
Affiliations
- PMID: 7507036
- DOI: 10.2165/00003495-199346050-00006
Item in Clipboard
Review
Drug treatment for hyperactive children. Therapeutic guidelines
Drugs.
1993 Nov.
Abstract
Attention deficit hyperactivity disorder (ADHD) is a common childhood behavioural disorder and medication is one of the principal treatments. Methylphenidate and dexamphetamine (dextroamphetamine) have a long record of use in children and well proven efficacy, and are the preferred drugs. Current clinical guidelines recommend a trial of methylphenidate and of dexamphetamine for each child meeting criteria for the disorder in order to maximise response rate and minimise adverse effects.
Similar articles
-
American Academy of Pediatrics Committee on Children with Disabilities, Committee on Drugs: Medication for children with an attention deficit disorder.Pediatrics. 1987 Nov;80(5):758-60. Pediatrics. 1987. PMID: 3670981 No abstract available.
-
Psychopharmacology of ADHD: children and adolescents.J Clin Psychiatry. 1998;59 Suppl 7:42-9. J Clin Psychiatry. 1998. PMID: 9680052 Review.
-
Treatment of attention-deficit/hyperactivity disorder.Evid Rep Technol Assess (Summ). 1999 Nov;(11):i-viii, 1-341. Evid Rep Technol Assess (Summ). 1999. PMID: 10790990 Free PMC article.
-
Relative efficacy of long-acting stimulants on children with attention deficit-hyperactivity disorder: a comparison of standard methylphenidate, sustained-release methylphenidate, sustained-release dextroamphetamine, and pemoline.Pediatrics. 1990 Aug;86(2):226-37. Pediatrics. 1990. PMID: 2196522 Clinical Trial.
-
Treatment of attention-deficit/hyperactivity disorder: overview of the evidence.Pediatrics. 2005 Jun;115(6):e749-57. doi: 10.1542/peds.2004-2560. Pediatrics. 2005. PMID: 15930203 Review.
Cited by
-
Diagnosis and management of children with attention deficit hyperactivity disorder.Indian J Pediatr. 2001 Jun;68(6):547-55. doi: 10.1007/BF02723251. Indian J Pediatr. 2001. PMID: 11450387 Review.
-
Methylphenidate and its isomers: their role in the treatment of attention-deficit hyperactivity disorder using a transdermal delivery system.CNS Drugs. 2006;20(9):713-38. doi: 10.2165/00023210-200620090-00002. CNS Drugs. 2006. PMID: 16953648 Review.
-
The biochemistry of Tourette's syndrome.Metab Brain Dis. 1995 Jun;10(2):107-24. doi: 10.1007/BF01991859. Metab Brain Dis. 1995. PMID: 7675010 Review. No abstract available.
-
Central Stimulant Treatment of Childhood Attention Deficit Hyperactivity Disorder : Issues and Recommendations from a US Perspective.CNS Drugs. 1997 Apr;7(4):264-72. doi: 10.2165/00023210-199707040-00002. CNS Drugs. 1997. PMID: 27520752
-
Safety issues in the use of methylphenidate. An American perspective.Drug Saf. 1997 Sep;17(3):143-8. doi: 10.2165/00002018-199717030-00001. Drug Saf. 1997. PMID: 9306050 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
